Skip to main content
Figure 6 | Molecular Medicine

Figure 6

From: Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot Study

Figure 6

ARA 290 patients demonstrated a significant improvement from baseline in the pain and physical functioning dimensions of the SF-36 quality of life questionnaire. In contrast to the placebo patients, those receiving ARA 290 showed significant improvement from baseline in the dimension of pain and physical functioning at wk 4 (**p< 0.01).

Back to article page